NCT01481961

"Who might be able to join this trial:

• You have been diagnosed with early Alzheimer's disease or a related memory/thinking condition, based on a specific set of recognised medical guidelines.
• You have been taking a type of medication used to treat Alzheimer's symptoms (called a cholinesterase inhibitor) for at least 3 months.
• Your condition is rated as mild to moderate on a standard memory and thinking assessment scale called the CDR (score of 2 or below).
• If you take any medications that affect mood or mental health, you may still be eligible as long as you have been on the same dose for at least 3 months without any changes.

Who may not be able to join:

• Your condition is rated as more severe on the CDR assessment scale (a score above 2).
• You have been diagnosed with a psychiatric condition such as depression (as defined by a specific set of medical guidelines), bipolar disorder, schizophrenia, or addiction.

Important: Always verify eligibility with the trial site directly before applying."